[HTML][HTML] Versican—a critical extracellular matrix regulator of immunity and inflammation
TN Wight, I Kang, SP Evanko, IA Harten… - Frontiers in …, 2020 - frontiersin.org
The extracellular matrix (ECM) proteoglycan, versican increases along with other ECM
versican binding molecules such as hyaluronan, tumor necrosis factor stimulated gene-6 …
versican binding molecules such as hyaluronan, tumor necrosis factor stimulated gene-6 …
Versican and versican-matrikines in cancer progression, inflammation, and immunity
Versican is an extracellular matrix proteoglycan with key roles in multiple facets of cancer
development, ranging from proliferative signaling, evasion of growth-suppressor pathways …
development, ranging from proliferative signaling, evasion of growth-suppressor pathways …
[HTML][HTML] Critical steps to tumor metastasis: alterations of tumor microenvironment and extracellular matrix in the formation of pre-metastatic and metastatic niche
J Zhuyan, M Chen, T Zhu, X Bao, T Zhen, K Xing… - Cell & Bioscience, 2020 - Springer
For decades, cancer metastasis has been a heated topic for its high mortality. Previous
research has shown that pre-metastatic niche and metastatic niche are the 2 crucial steps in …
research has shown that pre-metastatic niche and metastatic niche are the 2 crucial steps in …
[HTML][HTML] The novel diagnostic techniques and biomarkers of canine mammary tumors
I Kaszak, O Witkowska-Piłaszewicz, K Domrazek… - Veterinary …, 2022 - mdpi.com
Simple Summary The high rate of cancers in both humans and in animals along with their
poor overall survival pose a major challenge in medicine. Therefore, a large amount of …
poor overall survival pose a major challenge in medicine. Therefore, a large amount of …
[HTML][HTML] A complex and evolutive character: two face aspects of ECM in tumor progression
Tumor microenvironment, including extracellular matrix (ECM) and stromal cells, is a key
player during tumor development, from initiation, growth and progression to metastasis …
player during tumor development, from initiation, growth and progression to metastasis …
[HTML][HTML] Joint effect of THBS2 and VCAN accelerating the poor prognosis of gastric cancer
L Wang, L Feng, L Liu, J Han, X Zhang, D Li… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Objective: Gastric cancer is the most common malignant tumor of the digestive system. The
progression from gastritis to gastric cancer may be related to genetic factors, but the specific …
progression from gastritis to gastric cancer may be related to genetic factors, but the specific …
Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer
TY Yu, G Zhang, XX Chai, L Ren, DC Yin, CY Zhang - Life Sciences, 2023 - Elsevier
Breast cancer (BC) metastasis is an enormous challenge targeting BC therapy. The
extracellular matrix (ECM), the principal component of the BC metastasis niche, is the pivotal …
extracellular matrix (ECM), the principal component of the BC metastasis niche, is the pivotal …
Tenascin-C function in glioma: immunomodulation and beyond
First identified in the 1980s, tenascin-C (TNC) is a multi-domain extracellular matrix
glycoprotein abundantly expressed during the development of multicellular organisms. TNC …
glycoprotein abundantly expressed during the development of multicellular organisms. TNC …
[HTML][HTML] Single cell mass cytometry revealed the immunomodulatory effect of cisplatin via downregulation of splenic CD44+, IL-17A+ MDSCs and promotion of …
JÁ Balog, L Hackler Jr, AK Kovács… - International journal of …, 2019 - mdpi.com
The treatment of metastatic breast cancer remained a challenge despite the recent
breakthrough in the immunotherapy regimens. Here, we addressed the multidimensional …
breakthrough in the immunotherapy regimens. Here, we addressed the multidimensional …
[HTML][HTML] Proteoglycans in the pathogenesis of hormone-dependent cancers: mediators and effectors
Hormone-dependent cancers exhibit high morbidity and mortality. In spite of advances in
therapy, the treatment of hormone-dependent cancers remains an unmet health need. The …
therapy, the treatment of hormone-dependent cancers remains an unmet health need. The …